1. Home
  2. LSTA vs GENK Comparison

LSTA vs GENK Comparison

Compare LSTA & GENK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • GENK
  • Stock Information
  • Founded
  • LSTA 1980
  • GENK 2011
  • Country
  • LSTA United States
  • GENK United States
  • Employees
  • LSTA N/A
  • GENK N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • GENK Restaurants
  • Sector
  • LSTA Health Care
  • GENK Consumer Discretionary
  • Exchange
  • LSTA Nasdaq
  • GENK Nasdaq
  • Market Cap
  • LSTA 31.2M
  • GENK 36.5M
  • IPO Year
  • LSTA N/A
  • GENK 2023
  • Fundamental
  • Price
  • LSTA $2.50
  • GENK $5.42
  • Analyst Decision
  • LSTA Strong Buy
  • GENK Strong Buy
  • Analyst Count
  • LSTA 1
  • GENK 3
  • Target Price
  • LSTA $15.00
  • GENK $13.17
  • AVG Volume (30 Days)
  • LSTA 48.3K
  • GENK 66.1K
  • Earning Date
  • LSTA 02-27-2025
  • GENK 03-05-2025
  • Dividend Yield
  • LSTA N/A
  • GENK N/A
  • EPS Growth
  • LSTA N/A
  • GENK 483.78
  • EPS
  • LSTA N/A
  • GENK 0.17
  • Revenue
  • LSTA N/A
  • GENK $198,834,000.00
  • Revenue This Year
  • LSTA N/A
  • GENK $14.66
  • Revenue Next Year
  • LSTA N/A
  • GENK $21.47
  • P/E Ratio
  • LSTA N/A
  • GENK $31.05
  • Revenue Growth
  • LSTA N/A
  • GENK 12.50
  • 52 Week Low
  • LSTA $2.19
  • GENK $5.26
  • 52 Week High
  • LSTA $4.20
  • GENK $14.46
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 40.06
  • GENK 18.19
  • Support Level
  • LSTA $2.45
  • GENK $5.50
  • Resistance Level
  • LSTA $2.66
  • GENK $5.73
  • Average True Range (ATR)
  • LSTA 0.19
  • GENK 0.32
  • MACD
  • LSTA -0.00
  • GENK -0.03
  • Stochastic Oscillator
  • LSTA 20.00
  • GENK 11.85

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About GENK GEN Restaurant Group Inc.

GEN Restaurant Group Inc is an Asian casual dining restaurant in the United States. It offers an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables.

Share on Social Networks: